Alphamab Oncology 9966.HK
9966.HK
Alphamab Oncology 9887.HK
Leads Biolabs-b 2256.HK
Abbisko Cayman Limited 6826.HK
Shanghai Haohai Biological Technology Co., Ltd. 2157.HK
Lepu Biopharma Co., Ltd. 2142.HK
HBM Holdings Limited 2171.HK
CARsgen Therapeutics Holdings Limited 2186.HK
Luye Pharma Group Ltd. 2315.HK
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. 2616.HK
CStone Pharmaceuticals
Alphamab Oncology 9887.HK
Leads Biolabs-b 2256.HK
Abbisko Cayman Limited 6826.HK
Shanghai Haohai Biological Technology Co., Ltd. 2157.HK
Lepu Biopharma Co., Ltd. 2142.HK
HBM Holdings Limited 2171.HK
CARsgen Therapeutics Holdings Limited 2186.HK
Luye Pharma Group Ltd. 2315.HK
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. 2616.HK
CStone Pharmaceuticals
Performance
| Periode | 9966.HK | 9887.HK | 2256.HK | 6826.HK | 2157.HK | 2142.HK | 2171.HK | 2186.HK | 2315.HK | 2616.HK |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 117.04 % | -3.13 % | 124.71 % | 11.62 % | 70.20 % | 87.74 % | 35.79 % | 75.39 % | 92.88 % | 188.84 % |
| YTD | 319.53 % | -3.13 % | 248.53 % | 5.08 % | 167.46 % | 580.81 % | 84.43 % | 58.02 % | 174.22 % | 195.92 % |
| 1Y | 274.74 % | -3.13 % | 296.13 % | -20.06 % | 116.72 % | 961.42 % | 331.42 % | 8.41 % | 203.87 % | 302.78 % |
| 3Y | 141.85 % | -3.13 % | 426.37 % | 59.55 % | -12.69 % | 883.94 % | 29.69 % | 57.28 % | -15.70 % | 92.82 % |
| 5Y | -6.44 % | -3.13 % | 23.95 % | -16.59 % | -5.60 % | 22.32 % | -42.33 % | -27.65 % | -12.46 % | -40.57 % |
| 10Y | 6.59 % | -3.13 % | 23.95 % | -15.94 % | -5.60 % | 22.32 % | -42.33 % | -58.28 % | -12.46 % | -43.62 % |
| From the beginning | 6.59 % | -3.13 % | 23.95 % | -35.51 % | -5.60 % | 22.32 % | -42.33 % | -50.00 % | -12.46 % | -43.62 % |